Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127192992 | 12719299 | 2 | F | 20160816 | 20160906 | 20160907 | 20160919 | EXP | BR-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-123076 | RANBAXY | 0.00 | DY | M | Y | 2.42000 | KG | 20160919 | CN | US | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127192992 | 12719299 | 1 | SS | Tenofovir + Lamivudine | LAMIVUDINETENOFOVIR | 1 | Transplacental | 600 MG, DAILY | 0 | 600 | MG | ||||||||
| 127192992 | 12719299 | 2 | PS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Transplacental | UNK | U | 90923 | |||||||||
| 127192992 | 12719299 | 3 | SS | CEFTRIAXONE. | CEFTRIAXONE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 127192992 | 12719299 | 4 | SS | FERROUS SULFATE. | FERROUS SULFATE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 127192992 | 12719299 | 5 | SS | METRONIDAZOLE. | METRONIDAZOLE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 127192992 | 12719299 | 6 | SS | Sulphamethoxazole/Trimethoprim | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Transplacental | UNK | U | 0 | |||||||||
| 127192992 | 12719299 | 7 | SS | KALETRA | LOPINAVIRRITONAVIR | 1 | Transplacental | 1000 MG, DAILY | 0 | 1000 | MG | ||||||||
| 127192992 | 12719299 | 8 | SS | RETROVIR | ZIDOVUDINE | 1 | Transplacental | UNK UNK, DAILY | Y | 0 | |||||||||
| 127192992 | 12719299 | 9 | SS | RETROVIR | ZIDOVUDINE | 1 | Transplacental | UNK UNK, DAILY | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127192992 | 12719299 | 1 | HIV infection |
| 127192992 | 12719299 | 2 | Product used for unknown indication |
| 127192992 | 12719299 | 3 | Product used for unknown indication |
| 127192992 | 12719299 | 4 | Product used for unknown indication |
| 127192992 | 12719299 | 5 | Product used for unknown indication |
| 127192992 | 12719299 | 6 | Product used for unknown indication |
| 127192992 | 12719299 | 7 | HIV infection |
| 127192992 | 12719299 | 8 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127192992 | 12719299 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127192992 | 12719299 | Arnold-Chiari malformation | |
| 127192992 | 12719299 | Foetal exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127192992 | 12719299 | 1 | 20150505 | 0 | ||
| 127192992 | 12719299 | 7 | 20150505 | 0 | ||
| 127192992 | 12719299 | 8 | 20160816 | 20160816 | 0 | |
| 127192992 | 12719299 | 9 | 20160816 | 20160816 | 0 |